Nina Mojas

Nina Mojas is an accomplished executive with extensive experience in oncology product strategy, development, and business management. Currently serving as Senior Vice President of Oncology Global Product Strategy at GSK since May 2020, Mojas previously held leadership roles at AstraZeneca where responsibilities included serving as Oncology Business Unit Director and leading innovative programs such as the first-in-class PARP inhibitor. Additionally, Mojas played a pivotal role in strategic acquisitions and early portfolio management at AstraZeneca. Prior experience includes Investor Relations at Hoffmann-La Roche and healthcare investment advisory at Kepler Capital Markets. With a PhD in Molecular Biology from the University of Zurich, Mojas's career began in cancer research, establishing a strong foundation for subsequent leadership positions in the biopharmaceutical industry.